Angelia A Eick-Cost, Jeffrey W Thervil, Zheng Hu, Laurie S DeMarcus
{"title":"国防部人群季中流感疫苗有效性估计:在 VRBPAC--疫苗及相关生物制品咨询委员会--2024 年关于 2024-2025 年流感季节流感疫苗菌株选择的会议上提交的综合数据。","authors":"Angelia A Eick-Cost, Jeffrey W Thervil, Zheng Hu, Laurie S DeMarcus","doi":"","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":38856,"journal":{"name":"MSMR","volume":"31 3","pages":"20-23"},"PeriodicalIF":0.0000,"publicationDate":"2024-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Mid-season influenza vaccine effectiveness estimates among DOD populations: a composite of data presented at VRBPAC-the Vaccines and Related Biological Products Advisory Committee-2024 meeting on influenza vaccine strain selection for the 2024-2025 influenza season.\",\"authors\":\"Angelia A Eick-Cost, Jeffrey W Thervil, Zheng Hu, Laurie S DeMarcus\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":38856,\"journal\":{\"name\":\"MSMR\",\"volume\":\"31 3\",\"pages\":\"20-23\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"MSMR\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"MSMR","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
Mid-season influenza vaccine effectiveness estimates among DOD populations: a composite of data presented at VRBPAC-the Vaccines and Related Biological Products Advisory Committee-2024 meeting on influenza vaccine strain selection for the 2024-2025 influenza season.